港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

药捷安康-B

69.600

-0.700-1.00%

成交量：82.15万

成交额：5,707.70万

市值：277.70亿

市盈率：-79.83

高：71.600

开：70.350

低：68.800

收：70.300

52周最高：679.500

52周最低：20.200

股本：3.99亿

香港流通股本：3.04亿

量比：0.72

换手率：0.27%

股息：- -

股息率：- -

每股收益(LYR):-0.872

净资产收益率：-62.88%

总资产收益率：-32.06%

市净率：58.14

市盈率(LYR):-79.83

市销率: - -

数据加载中...

总览公司新闻资讯公告

港股异动 | 药捷安康-B(02617)拉升近14% 近日宣布在《柳叶刀》子刊发表替恩戈替尼积极临床结果

港股药捷安康-B尾盘跳水跌超10%

南方财经网

《股市简讯》中国生物科技公司药捷安康涨3.3%，一款药物纳入优先评审名单

药捷安康-B(02617)：替恩戈替尼片获国家药品监督管理局批准纳入优先审评品种名单

药捷安康-B盘中异动股价大跌5.10%

从四次递表到千亿市值，药捷安康核心管线替恩戈替尼解锁胆管癌治疗新可能

药捷安康-B11月26日主力净流入174.2万元散户资金抛售

南向游资套利路径隐现：“炒小、炒新、炒妖” 借纳入港股通安全撤退

药捷安康-B11月19日获主力加仓217.6万元

药捷安康-B跌2.06% 股价跌破200港元大关

多家银行出台方案优化供给金融精准服务新型工业化

药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”

药捷安康-B11月13日主力净流出409.9万元散户资金买入

药捷安康-B盘中异动大幅拉升4.77%报224.000港元

药捷安康-B11月11日主力净流出704.0万元散户资金买入

香港IPO集资额重登全球之巅惠理创始人谢清海剖析背后的“赢家密码”

智通港股通资金流向统计(T+2)|11月10日

生物医药股普跌药捷安康-B(02617)跌5.34%

港股综述｜三大指数午后回暖！航空股全天强势，锂电池、电力设备股强势拉升

老虎资讯综合

药捷安康(2617.HK)尾盘拉升涨超21%，与Neurocrine达成项目合作

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02617/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":69.6,"timestamp":1776326892006,"preClose":70.3,"halted":0,"volume":821500,"delay":0,"changeRate":-0.009957325746799472,"floatShares":304000000,"shares":399000000,"eps":-0.8717993426201284,"marketStatus":"未开盘","change":-0.7,"latestTime":"04-16 16:08:12","open":70.35,"high":71.6,"low":68.8,"amount":57077000,"amplitude":0.039829,"askPrice":69.7,"askSize":1000,"bidPrice":69.6,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-0.8717993426201284,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776389400000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":70.3,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.7196671047057294,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":304000000,"roa":"-32.06%","roe":"-62.88%","lyrEps":-0.871799,"volumeRatio":0.7196671047057294,"shares":399000000,"dividePrice":0,"high":71.6,"amplitude":0.039829,"preClose":70.3,"low":68.8,"week52Low":20.2,"pbRate":"58.14","week52High":679.5,"institutionHeld":0,"latestPrice":69.6,"committee":0.5,"eps":-0.8717993426201284,"divideRate":0,"volume":821500,"delay":0,"ttmEps":-0.8717993426201284,"open":70.35,"prevYearClose":114.9,"prevWeekClose":68.6,"prevMonthClose":66.5,"prevQuarterClose":66.5,"fiveDayClose":71.25,"twentyDayClose":76.65,"sixtyDayClose":100.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"market":"HK","date":"2026-03-31","symbol":"02617","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2026-04-15","current":-79.84477,"percent":0.7,"low":-380.446233,"twenty":-254.928912,"median":-113.347254,"eighty":-57.896187,"high":-17.403134,"avg":-149.738338,"sd":94.755164,"marketCap":28049533599},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-24","current":-293.038662,"twenty":-206.454369,"median":-63.574223,"eighty":-42.029097,"marketCap":75807447903},{"date":"2025-10-31","current":-281.572204,"twenty":-212.338922,"median":-65.741367,"eighty":-42.067733,"marketCap":72949784945},{"date":"2025-11-07","current":-338.772318,"twenty":-240.199465,"median":-68.232426,"eighty":-42.195906,"marketCap":87714376893},{"date":"2025-11-14","current":-312.135011,"twenty":-262.893893,"median":-70.289151,"eighty":-42.482614,"marketCap":81046496658},{"date":"2025-11-21","current":-312.892206,"twenty":-281.392507,"median":-71.392356,"eighty":-43.133487,"marketCap":81205255711},{"date":"2025-11-28","current":-305.66478,"twenty":-292.6573,"median":-72.756691,"eighty":-44.126885,"marketCap":79617665179},{"date":"2025-12-05","current":-292.058382,"twenty":-294.387608,"median":-99.507708,"eighty":-45.187328,"marketCap":76204345536},{"date":"2025-12-12","current":-243.995471,"twenty":-293.167092,"median":-152.573856,"eighty":-47.193393,"marketCap":63781449623},{"date":"2025-12-19","current":-248.269013,"twenty":-292.997062,"median":-174.177612,"eighty":-49.176233,"marketCap":65051522048},{"date":"2025-12-24","current":-196.609225,"twenty":-292.87226,"median":-176.029803,"eighty":-49.50215,"marketCap":51676071816},{"date":"2026-01-02","current":-170.268162,"twenty":-292.367293,"median":-176.029803,"eighty":-50.024601,"marketCap":44928812055},{"date":"2026-01-09","current":-172.395935,"twenty":-291.502465,"median":-173.687618,"eighty":-50.606284,"marketCap":45603538031},{"date":"2026-01-16","current":-142.824051,"twenty":-290.689477,"median":-172.622298,"eighty":-50.90198,"marketCap":37903723951},{"date":"2026-01-23","current":-125.658859,"twenty":-289.035292,"median":-170.268162,"eighty":-51.777834,"marketCap":33316302355},{"date":"2026-01-30","current":-123.813683,"twenty":-286.862177,"median":-169.566856,"eighty":-52.840115,"marketCap":32977154367},{"date":"2026-02-06","current":-105.494623,"twenty":-283.350344,"median":-167.82666,"eighty":-53.700055,"marketCap":28169232889},{"date":"2026-02-13","current":-102.143547,"twenty":-281.033113,"median":-142.637109,"eighty":-54.549461,"marketCap":27431087268},{"date":"2026-02-20","current":-99.091969,"twenty":-280.673719,"median":-140.820404,"eighty":-54.88737,"marketCap":26573242357},{"date":"2026-02-27","current":-101.401985,"twenty":-277.873293,"median":-135.446139,"eighty":-55.077905,"marketCap":27490936913},{"date":"2026-03-06","current":-136.499284,"twenty":-268.489172,"median":-127.818396,"eighty":-56.170035,"marketCap":36707782236},{"date":"2026-03-13","current":-113.20329,"twenty":-265.946326,"median":-125.658859,"eighty":-56.966285,"marketCap":30583168569},{"date":"2026-03-20","current":-101.699451,"twenty":-264.885138,"median":-122.419285,"eighty":-57.460964,"marketCap":27371237623},{"date":"2026-03-27","current":-103.891016,"twenty":-259.5894,"median":-118.720319,"eighty":-57.713018,"marketCap":27889934546},{"date":"2026-04-02","current":-103.689961,"twenty":-256.279611,"median":-116.735022,"eighty":-57.836913,"marketCap":27969734073},{"date":"2026-04-10","current":-80.663784,"twenty":-255.242863,"median":-113.754326,"eighty":-57.879207,"marketCap":27371237623},{"date":"2026-04-15","current":-82.483241,"twenty":-254.928912,"median":-113.347254,"eighty":-57.896187,"marketCap":28049533599}],"updateTime":1776374482723},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592957584","title":"港股异动 | 药捷安康-B(02617)拉升近14% 近日宣布在《柳叶刀》子刊发表替恩戈替尼积极临床结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2592957584","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592957584?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 10:33","pubTimestamp":1765938839,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药捷安康-B拉升近14%，截至发稿，涨13.85%，报166.1港元，成交额1.12亿港元。消息面上，据药捷安康官微消息，近日，公司宣布，核心产品替恩戈替尼在美国开展的针对胆管癌的探索性临床2期结果在《柳叶刀，胃肠病和肝病学》上发表。据悉，替恩戈替尼是一款自主研发、注册性临床阶段的创新多靶点小分子激酶抑制剂，通过靶向肿瘤细胞和改善肿瘤微环境发挥抗肿瘤作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"22a0e03e703ab82b83863db78ab69d04","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590313951","title":"港股药捷安康-B尾盘跳水跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590313951","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590313951?lang=zh_cn&edition=fundamental","pubTime":"2025-12-09 15:31","pubTimestamp":1765265502,"startTime":"0","endTime":"0","summary":"港股药捷安康-B尾盘跳水跌超10%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512093586422675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588607413","title":"《股市简讯》中国生物科技公司药捷安康涨3.3%，一款药物纳入优先评审名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2588607413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588607413?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 11:00","pubTimestamp":1764817204,"startTime":"0","endTime":"0","summary":"《股市简讯》中国生物科技公司药捷安康涨3.3%，一款药物纳入优先评审名单* 中国生物科技公司--药捷安康2617.HK周四早盘一度升3.3%。* 该公司此前公告称，替恩戈替尼片已获中国国家药监局药品审评中心批准纳入优先审评品种名单，拟定适应症为：用于既往至少接受过一种系统性治疗和FGFR抑制剂治疗的晚期、转移性或不可手术切除的胆管癌成人患者的治疗。* 恒⽣⽣物科技指数.HSBIO盘中一度升1.4%。（完）更多股市简讯请点选CN-CMN-HOT (发稿 徐凯文；审校 吴云凌) ((kaiwen.xu@thomsonreuters.com))","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4S3XA067:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588466011","title":"药捷安康-B(02617)：替恩戈替尼片获国家药品监督管理局批准纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2588466011","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588466011?lang=zh_cn&edition=fundamental","pubTime":"2025-12-03 17:12","pubTimestamp":1764753145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，替恩戈替尼片已获中国国家药品监督管理局(NMPA)药品审评中心(CDE)批准纳入优先审评品种名单，拟定适应症为：用于既往至少接受过一种系统性治疗和FGFR抑制剂治疗的晚期、转移性或不可手术切除的胆管癌成人患者的治疗。此前，替恩戈替尼已获NMPA授予治疗胆管癌的突破性治疗品种认定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617)：替恩戈替尼片获国家药品监督管理局批准纳入优先审评品种名单","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588083249","title":"药捷安康-B盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588083249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588083249?lang=zh_cn&edition=fundamental","pubTime":"2025-12-02 11:17","pubTimestamp":1764645460,"startTime":"0","endTime":"0","summary":"2025年12月02日早盘11时17分，药捷安康-B股票出现异动，股价大幅跳水5.10%。截至发稿，该股报186.000港元/股，成交量16.28万股，换手率0.05%，振幅6.58%。资金方面，该股资金流入721.28万港元，流出1528.15万港元。药捷安康-B股票所在的生物技术行业中，整体跌幅为1.60%。药捷安康-B公司简介：药捷安康(南京)科技股份有限公司是一家从事生物制药的中国公司,主要专注于发现及开发肿瘤、炎症及心脏代谢疾病小分子创新疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512021117409525dd7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512021117409525dd7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588083277","title":"从四次递表到千亿市值，药捷安康核心管线替恩戈替尼解锁胆管癌治疗新可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2588083277","media":"制药在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588083277?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 13:16","pubTimestamp":1764566189,"startTime":"0","endTime":"0","summary":"11月25日，CDE官网显示，药捷安康的替恩戈替尼片拟纳入优先审评，用于既往至少接受过一种系统性治疗和FGFR抑制剂治疗的晚期、转移性或不可手术切除的胆管癌成人患者的治疗。目前，替恩戈替尼正在开展多项针对胆管癌、肝细胞癌、前列腺癌、乳腺癌等实体瘤的临床试验，其中胆管癌适应症于2023年7月被CDE纳入突破性治疗程序。业界分析公司股价的暴涨与核心产品替恩戈替尼的进展密切相关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120113163797890334&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120113163797890334&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586656782","title":"药捷安康-B11月26日主力净流入174.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2586656782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586656782?lang=zh_cn&edition=fundamental","pubTime":"2025-11-26 16:15","pubTimestamp":1764144943,"startTime":"0","endTime":"0","summary":"11月26日, 药捷安康-B股价涨2.32%，报收202.60元，成交金额1.1亿元，换手率0.18%，振幅5.20%，量比0.65。药捷安康-B今日主力资金净流入174.2万元，上一交易日主力净流出178.2万元。该股近5个交易日下跌0.10%，主力资金累计净流出13.5万元；近20日主力资金累计净流入6598.1万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161949a7127c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126161949a7127c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585246913","title":"南向游资套利路径隐现：“炒小、炒新、炒妖” 借纳入港股通安全撤退","url":"https://stock-news.laohu8.com/highlight/detail?id=2585246913","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585246913?lang=zh_cn&edition=fundamental","pubTime":"2025-11-24 19:34","pubTimestamp":1763984045,"startTime":"0","endTime":"0","summary":"【南向游资套利路径隐现：“炒小、炒新、炒妖” 借纳入港股通安全撤退】在市场结构深刻变革的背后，新的风险因素正在积聚。业内观察发现，部分内地游资正通过系统化的资本运作，利用港股通机制进行跨市场套利。招商证券（香港）分析师宁铂表示，2025年以来，游资已形成“选中标的—暴力拉升—助推入通—被动资金接盘—成功出货”的完整运作链条。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511243573161622.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511243573161622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FDN","HHImain","399300","06681","BK4550","BK1189","02609","HSI","MCHmain","MHImain","02617","BK4588","02833","BK4585","BK1161","513600","BK1209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584257229","title":"药捷安康-B11月19日获主力加仓217.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584257229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584257229?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 16:15","pubTimestamp":1763540155,"startTime":"0","endTime":"0","summary":"11月19日, 药捷安康-B股价涨1.10%，报收202.80元，成交金额1.1亿元，换手率0.19%，振幅4.34%，量比0.47。药捷安康-B今日主力资金净流入217.6万元，上一交易日主力净流入25万元。该股近5个交易日下跌3.90%，主力资金累计净流出17.0万元；近20日主力资金累计净流入7730.5万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119162134950dff1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119162134950dff1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584969641","title":"药捷安康-B跌2.06% 股价跌破200港元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2584969641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584969641?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:44","pubTimestamp":1763343895,"startTime":"0","endTime":"0","summary":"2025年11月17日早盘09时44分，药捷安康-B股票出现异动，股价急速跳水2.06%。截至发稿，该股报200.000港元/股，成交量5.9万股，换手率0.02%，振幅3.43%。资金方面，该股资金流入172.68万港元，流出554.89万港元。药捷安康-B股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，来凯医药-B、派格生物医药-B、云康集团涨幅较大，振幅较大的相关个股有派格生物医药-B、MIRXES-B、来凯医药-B，振幅分别为27.98%、11.60%、10.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117094455976dc6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117094455976dc6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584695843","title":"多家银行出台方案优化供给 金融精准服务新型工业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2584695843","media":"经济日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584695843?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 09:32","pubTimestamp":1763256720,"startTime":"0","endTime":"0","summary":"近日，中国建设银行、中国银行等发布落实《意见》要求的相关实施方案，进一步细化与新型工业化相适应的金融机制，全面支持我国新型工业化深入发展。截至今年6月末，中国银行工业领域供应链融资余额及科技型企业贷款余额双双突破2.3万亿元，保持较快增长势头。中国光大银行推出支持新型工业化金融服务方案，通过40项具体工作举措，全面支持新型工业化深入推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116093421a6fc4400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116093421a6fc4400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583363717","title":"药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”","url":"https://stock-news.laohu8.com/highlight/detail?id=2583363717","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583363717?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 16:43","pubTimestamp":1763196217,"startTime":"0","endTime":"0","summary":"“我们正在中国香港进行IPO路演，但这段时间药企扎堆申报港股IPO，已形成了‘堰塞湖’，基石投资者和锚定投资者都快看不过来了，我们遭遇路演排队。”有赴港IPO药企人士对第一财经记者透露。今年以来，港股医药二级市场的复苏，提振了企业们IPO融资热情。根据Choice金融终端数据，截至11月14日，港股的医疗保健板块今年累计迎来了23家企业成功上市，而去年同期仅有8家企业上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["LU0594300179.USD","LU1064131003.USD","LU0605514214.HKD","SGXZ49509284.SGD","LU1688375341.USD","LU0359201612.USD","LU2153592121.USD","SGXZ81163826.USD","IE00B29SXG58.USD","BK4104","LU1997244956.HKD","HK0000252152.HKD","688506","LU1064130708.USD","09887","BK1515","LU1734074674.USD","LU1146622755.USD","LU2097828474.EUR","LU2097828714.EUR","LU2213484517.USD","GIC","LU0405327494.USD","LU1655091616.SGD","LU1580142542.USD","LU1781817850.SGD","LU2153591404.USD","02617","HK0000500386.USD","09939","LU2148510915.USD","LU1720050803.USD","02615","LU1328615791.USD","LU1934453819.USD","LU1023057109.AUD","LU1979443071.USD","300558","LU0823426308.USD","02591","02595","09606","HK0000252160.HKD","300760","LU0572944931.SGD","600276","IE0031814852.USD","BK0196","LU2580892862.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583523515","title":"药捷安康-B11月13日主力净流出409.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2583523515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583523515?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:15","pubTimestamp":1763021705,"startTime":"0","endTime":"0","summary":"11月13日, 药捷安康-B股价跌1.52%，报收207.00元，成交金额2.6亿元，换手率0.41%，振幅6.57%，量比0.51。药捷安康-B今日主力资金净流出409.9万元，上一交易日主力净流入29.8万元。该股近5个交易日下跌5.81%，主力资金累计净流入1684.0万元；近20日主力资金累计净流入7651.5万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113161516a6f67580&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251113161516a6f67580&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582942317","title":"药捷安康-B盘中异动 大幅拉升4.77%报224.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582942317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582942317?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 09:40","pubTimestamp":1762911658,"startTime":"0","endTime":"0","summary":"2025年11月12日早盘09时40分，药捷安康-B股票出现异动，股价急速拉升4.77%。截至发稿，该股报224.000港元/股，成交量23.8628万股，换手率0.08%，振幅5.14%。资金方面，该股资金流入1984.02万港元，流出1475.2万港元。药捷安康-B股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，中生北控生物科技、药捷安康-B、百济神州涨幅较大，振幅较大的相关个股有荣昌生物、来凯医药-B、药捷安康-B，振幅分别为8.11%、7.77%、5.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111209405897639ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111209405897639ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582317920","title":"药捷安康-B11月11日主力净流出704.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2582317920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582317920?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 16:15","pubTimestamp":1762848955,"startTime":"0","endTime":"0","summary":"11月11日, 药捷安康-B股价跌8.24%，报收213.80元，成交金额3.3亿元，换手率0.50%，振幅10.21%，量比0.51。药捷安康-B今日主力资金净流出704.0万元，上一交易日主力净流入1984.6万元。该股近5个交易日上涨18.12%，主力资金累计净流入5642.6万元；近20日主力资金累计净流入8031.5万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111162149976214a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111162149976214a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582844837","title":"香港IPO集资额重登全球之巅 惠理创始人谢清海剖析背后的“赢家密码”","url":"https://stock-news.laohu8.com/highlight/detail?id=2582844837","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582844837?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 14:01","pubTimestamp":1762754460,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，多只重磅新股在港交所上市，推动香港新股市场今年表现亮丽，重夺首次公开发行集资额冠军豪无悬念。谢清海称，将香港建设、巩固和发展成为国际金融中心，不仅对香港本身至关重要，对国家同样重要。香港行政长官李家超上周出席国际金融领袖投资峰会主峰会时表示，香港今年首10个月，新股集资额全球排名第一，期内共有80宗IPO，集资额超过260亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1807302812.USD","LU1993786604.SGD","BK1156","LU1960683339.HKD","IPO","BK1198","HEXmain","02617","BK1610","BK1116","BK1161","00806"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2582252819","title":"智通港股通资金流向统计(T+2)|11月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2582252819","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582252819?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 07:31","pubTimestamp":1762731060,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，11月5日,南方恒生科技、阿里巴巴-W、小米集团-W南向资金净流入金额位列市场前三，分别净流入12.86 亿、8.85 亿、6.50 亿华虹半导体、中芯国际、哔哩哔哩-W南向资金净流出金额位列市场前三，分别净流出-6.42 亿、-5.05 亿、-1.88 亿在净流入比方面，青岛银行、中国通号、大唐新能源以83.58%、56.27%、55.14%位列市场前三。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HXXD.SI","01055","81810","02192","02899","00883","MCHmain","00548","XIACY","81024","03033","02800","00990","03866","00763","00257","03403","00939","02828","02273","01798","02419","02601","80883","IE00B3M56506.USD","00991","01398","06869","09636","00639","09988","89988","00168","02039","00667","02460","02617","03969","00966","HBBD.SI","01810","02382","KSTmain","03143","09626","00308"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2581080038","title":"生物医药股普跌 药捷安康-B(02617)跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581080038","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581080038?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 10:07","pubTimestamp":1762394826,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股普跌，药捷安康-B 跌5.34%，科伦博泰生物-B跌5.20%，康诺亚-B跌4.52%，药师帮跌4.46%，映恩生物-B跌3.95%，佰泽医疗跌3.69%，乐普生物-B跌3.32%，再鼎医药跌3.16%，脑动极光-B跌2.96%，亚盛医药-B跌2.75%。交银国际表示，医药行业板块3Q25业绩呈现边际复苏态势，其中与创新产业链关联紧密的化药/生物药公司和CXO板块表现较优，集采影响逐步出清的子板块也有改善迹象。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969129","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1189","09688","BK1583","BK1574","06855","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","LU2488822045.USD","399441","LU2543165471.USD","02157","02617","BK1161","06990","09606","02609","09885","BK1197","LU0196878994.USD","BK1209","BK1588","06681","02162","BK1587","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138049857","title":"港股综述｜三大指数午后回暖！航空股全天强势，锂电池、电力设备股强势拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=1138049857","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138049857?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:33","pubTimestamp":1762331602,"startTime":"0","endTime":"0","summary":"恒指微跌0.07%，航空股全天维持强势，锂电池、电力设备股强势拉升11月5日，午后市场明显回暖，恒生指数、国企指数一度转涨，最终分别收跌0.07%及0.11%，恒指在26000点附近反复震荡，恒生科技指数跌0.56%相对最弱，三大指数均呈现低开高走行情。A股行情A股收评：低开高走！全市场成交额1.89万亿元，较前一交易日缩量441亿元，近3400股上涨。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f0e8db0f06f95058464db3c9adf61f49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","HSI","HSTECH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581495087","title":"药捷安康(2617.HK)尾盘拉升涨超21%，与Neurocrine达成项目合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2581495087","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581495087?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:17","pubTimestamp":1762330622,"startTime":"0","endTime":"0","summary":"药捷安康-B尾盘拉升涨超21%。药捷安康近日公告，Neurocrine与本公司订立一项付特许权使用费的专利转让及研究合作协议，以开发NLRP3抑制剂，用于治疗多种疾病。根据该协议，公司将有权获得预付款，并且根据Neurocrine的开发和商业化进展，公司可能会收到与研发里程碑和销售里程碑相关的进一步里程碑付款，该协议的总潜在价值为8.815亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251105/31769637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02617","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":106,"code":"91000000","status":"200"}]}}